Fennec Pharmaceuticals Inc. (FENC): Price and Financial Metrics
FENC Price/Volume Stats
| Current price | $5.99 | 52-week high | $11.92 |
| Prev. close | $5.84 | 52-week low | $3.96 |
| Day low | $5.73 | Volume | 172,900 |
| Day high | $6.00 | Avg. volume | 118,721 |
| 50-day MA | $5.08 | Dividend yield | N/A |
| 200-day MA | $6.71 | Market Cap | 164.55M |
FENC Stock Price Chart Interactive Chart >
Fennec Pharmaceuticals Inc. (FENC) Company Bio
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, a water soluble thiol compound that acts as a chemical reducing agent, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was founded in 1996 and is based in Research Triangle Park, North Carolina.
FENC Price Returns
| 1-mo | 26.91% |
| 3-mo | 14.31% |
| 6-mo | -5.67% |
| 1-year | -45.35% |
| 3-year | 38.98% |
| 5-year | 102.71% |
| YTD | -46.61% |
| 2023 | 16.88% |
| 2022 | 118.18% |
| 2021 | 18.12% |
| 2020 | 14.79% |
| 2019 | 1.72% |
Loading social stream, please wait...